ArticleJournal of the American Society of Nephrology : JASN2026

B -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.

Xianghua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.